Dear investors,

Unilabs reopened its investor relations section as of May 5th, 2017, following the pricing of its senior notes offering (announcement).

All financial press releases that will be published from this day will be accessible via our News section.

We value your interest in Unilabs and should you have any pressing questions with regards to company finances, please contact us on

About Unilabs: With over 196 laboratories and 44 imaging units and a broad catalogue of more than 2,500 diagnostic tests, Unilabs is one of Europe’s leading providers of clinical laboratory testing and medical diagnostic imaging services. Headquartered in Geneva, the Unilabs Group services sectors ranging from private and public healthcare providers to local governments, from pharmaceutical companies to the general public. The company employs more than 6,800 people worldwide, successfully operating laboratory and medical diagnostic imaging facilities in 14 countries, and generating annual revenues of €790 m in 2016. Its network of facilities provides its customers with one of the broadest geographic footprints of any clinical laboratory and medical diagnostic services provider in Europe.